Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Relistor

- PMLiVE

FDA allows accelerated review for rivals to over-priced drugs

Aims to combat growing trend in exploitation of sole-source drug pricing

- PMLiVE

As CEO returns, Valeant admits SEC probe

Embattled firm's problems continue

Deal Watch January 2016

Shire, Roche, Sanofi, BMS and Merck & Co are among those featured in this month's roundup of M&A and other pharma deal activity

- PMLiVE

Forging a path in specialty care

Takeda’s Marc Princen on the company’s plans to build a reputation in oncology, gastroenterology and vaccine

- PMLiVE

Zeno Group acquires 3 Monkeys Communications

Strikes deal as a part of the agency’s continued global expansion

- PMLiVE

2015’s ‘premium’ prices dissuaded J&J from acquisitions, says Gorsky

More M&A activity anticipated in 2016 and beyond

- PMLiVE

Acorda acquires Biotie to expand in Parkinson’s disease

Strikes $363m deal for Finnish firm

Weber Shandwick acquires US healthcare communications firm

Strikes deal with ReviveHealth in bid to boost its integrated health comms services

Deal Watch December 2015

The month’s deals see a number of collaboration and licensing deals for technology platforms and new molecule discovery

- PMLiVE

Valeant names Schiller interim CEO as Pearson battles illness

Former CFO fills in and Ingram is appointed interim chairman of the board

Shire Basingstoke

Shire deal with Baxalta predicted this week

Takeover talks reported to be at an advanced stage

- PMLiVE

AZ takes majority stake in cancer drug developer Acerta

Will pay $4bn for a 55% share in the Dutch biopharma company

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links